Nerve signals may foretell pain relief: a new test for chronic arm pain?

NCT ID NCT07776431

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study explores whether nerve conduction tests can predict how well patients with chronic neck-related arm pain respond to a treatment called pulsed radiofrequency. Adults aged 18 to 75 with pain lasting at least 3 months will have nerve tests before the procedure. Researchers will then compare pain, disability, quality of life, and mood between those with and without nerve damage evidence, to see if the tests can forecast treatment success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pulsed radiofrequency treatment to the dorsal root ganglion, with pre-procedure nerve conduction studies (electromyography and nerve conduction study) used as a predictive test.
What this could lead to
If nerve tests predict who benefits, doctors could better select patients for this procedure, improving outcomes and avoiding unnecessary treatments.
What could go wrong
This is a small observational study, so results may not apply broadly. The predictive value of nerve tests is uncertain, and the procedure itself carries risks like pain or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adults aged 18 to 75 years with unilateral chronic cervical radicular pain lasting at least 3 months due to cervical disc herniation and/or spinal stenosis. Eligible participants have persistent symptoms despite conservative treatments and are already scheduled to undergo cervical dorsal root ganglion pulsed radiofrequency treatment as part of routine clinical care. Before treatment, all participants undergo electromyography and nerve conduction studies and are classified according to the presence or absence of electrophysiological evidence of cervical radiculopathy.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age between 18 and 75 years Presence of cervical disc herniation and/or spinal stenosis Unilateral cervical radicular pain radiating to the arm for at least 3 months, confirmed by clinical evaluation, physical examination, and radiological imaging Inadequate response to conservative treatments, including physical therapy, medical treatment, and/or epidural steroid injection Exclusion Criteria: History of cervical spine surgery Presence of myelopathy Predominantly axial neck pain Active infection Vertebral fracture Coagulation disorder Presence of a cardiac pacemaker Refusal or inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic cervical radicular pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Marmara University Pendik Training and Research Hospital

    Istanbul, Pendik, 34899, Turkey (Türkiye)